Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients

NCT05417997 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Respiratory Infection
FLU
Cold; Influenza
Bacterial Pneumonia
COVID-19 Pneumonia

Interventions

DIETARY_SUPPLEMENT: Kunamin®
DRUG: Favipiravir
DRUG: Enoxaparin
DRUG: Lansoprazole
DRUG: Paracetamol
DRUG: Ceftriaxone/ Clarithromycin
DRUG: Methylprednisolone

Sponsor

RAAS Nutritionals, LLC

Collaborators

[object Object]